Oct 10, 2022Tamas Sohajdadrug developmentaging, alzheimers, cyclodextrin, neurodegenerative diseases Cyclo Therapeutics, Inc. goes for Phase 2b Study of Trappsol® Cyclo™ for treating early Alzheimer’s disease. See full post…